1. Management Strategies and Outcomes of Hemorrhagic Traumatic Brain Injury on Oral Anticoagulants
- Author
-
Megan M Finneran, Evan M Krueger, and Michelle Smith
- Subjects
medicine.medical_specialty ,business.industry ,Traumatic brain injury ,traumatic brain injury ,Incidence (epidemiology) ,Neurosurgery ,General Engineering ,Glasgow Coma Scale ,Emergency department ,030204 cardiovascular system & hematology ,antiplatelet ,medicine.disease ,Trauma ,Triage ,03 medical and health sciences ,0302 clinical medicine ,Patient age ,Internal medicine ,Hospital discharge ,Medicine ,Observational study ,anticoagulation ,business ,intracranial hemorrhage ,030217 neurology & neurosurgery - Abstract
Introduction: Traumatic brain injury (TBI) is common, and the frequency of patients taking oral anticoagulants is increasing. However the optimal initial triage, management, and long term care plans of hemorrhagic TBI patients taking oral anticoagulants is not clear. Objectives: To determine the usage pattern of reversal agents for hemorrhagic TBI patients taking oral anticoagulants, and examine their characteristics and outcomes as compared to hemorrhagic TBI patients not taking these medications. Methods: This was a single-center, retrospective, observational study. Included were adults with trauma categorization and traumatic intracranial hemorrhage (ICH) between April 1, 2017 and December 31, 2019. Patient age, type of ICH, initial Glasgow Coma Scale (GCS) score, oral anticoagulant prescribed pre-injury, anticoagulation reversal agent given, and hospital discharge disposition were recorded. Results: For the entire sample size (n=111), the mean age and GCS were 71.6 years old and 13.8, respectively. Compared to patients not taking oral anticoagulants, patients taking oral anticoagulants were older (76.7 years old versus 69.1; p
- Published
- 2020
- Full Text
- View/download PDF